Brokerages Expect Motus GI Holdings Inc (MOTS) to Announce -$0.27 Earnings Per Share

Share on StockTwits

Brokerages predict that Motus GI Holdings Inc (NASDAQ:MOTS) will post earnings of ($0.27) per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Motus GI’s earnings, with the lowest EPS estimate coming in at ($0.28) and the highest estimate coming in at ($0.27). The firm is scheduled to announce its next quarterly earnings report on Tuesday, November 13th.

According to Zacks, analysts expect that Motus GI will report full-year earnings of ($1.24) per share for the current financial year, with EPS estimates ranging from ($1.32) to ($1.12). For the next fiscal year, analysts anticipate that the business will report earnings of ($0.90) per share, with EPS estimates ranging from ($1.04) to ($0.78). Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Motus GI.

Motus GI (NASDAQ:MOTS) last posted its quarterly earnings data on Tuesday, August 14th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.01). The firm had revenue of $0.03 million for the quarter.

A number of analysts have recently issued reports on the stock. Oppenheimer set a $10.00 price objective on shares of Motus GI and gave the company a “buy” rating in a report on Wednesday, August 15th. LADENBURG THALM/SH SH assumed coverage on shares of Motus GI in a report on Thursday, August 30th. They issued a “buy” rating and a $14.50 price objective on the stock. Zacks Investment Research downgraded shares of Motus GI from a “hold” rating to a “sell” rating in a report on Wednesday, July 18th. Dougherty & Co assumed coverage on shares of Motus GI in a report on Tuesday, August 28th. They issued a “buy” rating and a $8.00 price objective on the stock. Finally, ValuEngine upgraded shares of Motus GI from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $10.50.

NASDAQ MOTS opened at $5.24 on Tuesday. Motus GI has a 12-month low of $3.75 and a 12-month high of $10.66. The company has a market capitalization of $83.09 million and a PE ratio of -4.09.

Institutional investors and hedge funds have recently modified their holdings of the stock. IPG Investment Advisors LLC acquired a new position in Motus GI during the second quarter worth $106,000. Quantitative Systematic Strategies LLC acquired a new position in Motus GI during the second quarter worth $113,000. Hilltop Holdings Inc. acquired a new position in Motus GI during the first quarter worth $502,000. Finally, Highbridge Capital Management LLC acquired a new position in Motus GI during the first quarter worth $896,000. Institutional investors and hedge funds own 21.61% of the company’s stock.

Motus GI Company Profile

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Recommended Story: Using the New Google Finance Tool

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply